HC Wainwright restated their buy rating on shares of Eledon Pharmaceuticals (NASDAQ:ELDN – Free Report) in a research note released on Friday morning, Benzinga reports. HC Wainwright currently has a $13.00 price objective on the stock. Eledon Pharmaceuticals Stock Performance Shares of NASDAQ ELDN opened at $2.07 on Friday. The firm’s 50-day simple moving average […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 65,300 shares, a growth of 147.3% from the November 30th total of 26,400 shares. Based on an average daily volume of 97,400 shares, […]
Eledon Pharmaceuticals (NASDAQ:ELDN – Free Report) had its target price cut by HC Wainwright from $25.00 to $13.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Eledon Pharmaceuticals’ FY2023 earnings at ($1.31) EPS. A number of other research firms […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) saw a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 15,200 shares, a decline of 47.0% from the March 31st total of 28,700 shares. Based on an average daily volume of 26,700 shares, the short-interest ratio is […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating)’s stock price traded down 4.3% during mid-day trading on Friday . The company traded as low as $2.40 and last traded at $2.44. 11,463 shares were traded during trading, a decline of 55% from the average session volume of 25,521 shares. The stock had previously closed at $2.55. […]